Cytokine evaluation in liver cirrhosis and hepatocellular carcinoma.

Abstract

IL-18 may be a potential tumour marker in combination with IL-6 and AFP in the diagnosis of HCC, but further research including a larger population of patients is essential. Further research is warranted.